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ABSTRACT  
   
The American Diabetes Association reports that diabetes costs $322 billion annually and 
affects 29.1 million Americans. The high out-of-pocket cost of managing diabetes can 
lead to noncompliance causing serious and expensive complications. There is a large 
market potential for a more cost-effective alternative to the current market standard of 
screen-printed self-monitoring blood glucose (SMBG) strips. Additive manufacturing, 
specifically 3D printing, is a developing field that is growing in popularity and 
functionality. 3D printers are now being used in a variety of applications from consumer 
goods to medical devices. Healthcare delivery will change as the availability of 3D 
printers expands into patient homes, which will create alternative and more cost-effective 
methods of monitoring and managing diseases, such as diabetes. 3D printing technology 
could transform this expensive industry. A 3D printed sensor was designed to have 
similar dimensions and features to the SMBG strips to comply with current 
manufacturing standards. To make the sensor electrically active, various conductive 
filaments were tested and the conductive graphene filament was determined to be the best 
material for the sensor. Experiments were conducted to determine the optimal print 
settings for printing this filament onto a mylar substrate, the industry standard. The 
reagents used include a mixture of a ferricyanide redox mediator and flavin adenine 
dinucleotide dependent glucose dehydrogenase. With these materials, each sensor only 
costs $0.40 to print and use. Before testing the 3D printed sensor, a suitable design, 
voltage range, and redox probe concentration were determined. Experiments 
demonstrated that this novel 3D printed sensor can accurately correlate current output to 
glucose concentration. It was verified that the sensor can accurately detect glucose levels 
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from 25 mg/dL to 400 mg/dL, with an R2 correlation value as high as 0.97, which was 
critical as it covered hypoglycemic to hyperglycemic levels. This demonstrated that a 3D-
printed sensor was created that had characteristics that are suitable for clinical use. This 
will allow diabetics to print their own test strips at home at a much lower cost compared 
to SMBG strips, which will reduce noncompliance due to the high cost of testing. In the 
future, this technology could be applied to additional biomarkers to measure and monitor 
other diseases. 
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CHAPTER 1 
INTRODUCTION 
Market Need 
Current devices on the market for monitoring and managing diabetes are invasive and 
expensive. Many times, the pain and price of managing diabetes leads to noncompliance 
among diabetics. There is a need for a device that is not only non-invasive, but also 
inexpensive. New technologies, such as 3D printing, could be utilized to provide new 
options for diabetics to monitor their blood glucose levels. Use of 3D printed technology 
in healthcare is growing in popularity as 3D printing is becoming an inexpensive 
technology and the availability of 3D printers is expanding. The focus of this research 
was to utilize concepts of electrochemistry to develop a viable and affordable 3D printed 
sensor for diabetics to monitor their blood glucose levels.  
 
Overview of Diabetes 
According to the World Health Organization, there are 422 million diabetics worldwide 
[10]. The American Diabetes Association reports that there are 29.1 million diabetics in 
the United States [23]. Globally, there are 1.5 million diabetes related deaths each year 
[10]. The prevalence of diabetes is expected to grow and it is projected to be the seventh 
leading cause of death by 2030 [10]. 
There are two types of diabetes - type 1 and type 2. Individuals with type 1 diabetes 
usually develop a predisposition for the disease early in life and affects 5% of all 
diabetics [25]. Type 1 diabetes is a chronic autoimmune disorder where the body’s 
immune system attacks beta cells [5]. Beta cells are important as they produce insulin, 
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which is a hormone produced by the pancreas that metabolizes glucose. Insulin is 
responsible for keeping blood glucose levels within a healthy range and avoiding 
glycemic spikes. Once the beta-cells have been destroyed by the immune system, 
production of insulin is no longer possible [6]. Individuals with type 1 diabetes are 
therefore unable to regulate their own blood glucose levels. 
Type 2 diabetes is more common than type 1 and occurs when individuals can no longer 
metabolize sugar [19]. Individuals with type 2 diabetes are either resistant to insulin or 
unable to produce enough insulin which leads to above normal blood glucose levels [19]. 
Risk factors for type 2 diabetes include: poor diet, lack of exercise, family history, 
overweight, and high blood pressure [21].  
The glycemic spikes in both types of diabetes can lead to very serious complications. 
These complications include: cardiovascular disease, neuropathy, nephropathy, 
retinopathy, and ketoacidosis [9]. If left untreated, these complications can lead to 
premature death in diabetics. To avoid these complications, diabetics must maintain a 
healthy diet, exercise, take all prescribed medication, and comply with doctors’ blood 
glucose testing schedules [22]. These steps help to control glycemic levels, which can 
slow or prevent diabetes related complications [22]. Although it is very important to 
comply with prescribed testing schedules, patients often do not adhere to these schedules 
as testing with current monitoring devices is often painful and expensive.  
 
Current Blood Glucose Monitoring Technology 
Self-monitoring blood glucose (SMBG) devices are the most widely used monitoring 
technology for diabetics. SMBG devices require the user to obtain a blood sample using a 
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lancet. This blood sample is then placed onto a test strip, which is then inserted into a 
monitor device. This monitor provides the user with their current blood glucose levels. If 
the blood glucose levels are outside of the normal range, the patient must correct them 
accordingly. Hyperglycemic levels require the diabetic to inject insulin, while 
hypoglycemic levels require the diabetic to ingest food with glucose or simple 
carbohydrates [14]. Although SMBG devices are relatively easy to use, provide fast 
results, and allow the user to test anywhere, noncompliance remains an issue with this 
device. This is because collecting the blood sample is often painful and the test strips are 
expensive. The average price for a single SMBG test strip is $0.98 [27]. These test strips 
should not be reused, raising the overall cost of monitoring this disease when testing 
multiple times a day. The number of tests required per day depends on the severity and 
management of the disease. Physicians help create a testing schedule for diabetics, which 
is critical to help patients maintain healthy glycemic levels. Therefore, it is essential these 
SMBG monitoring devices provide accurate readings but unfortunately, many are prone 
to various errors. The reported blood glucose levels can easily produce errors if the user 
does not have clean skin in the area where the blood sample is collected [3]. Errors can 
also occur if there is a delay in getting the blood sample testing strip into the monitor [3]. 
Continuous glucose monitoring (CGM) devices are a growing technology in managing 
diabetes. In CGM devices, a glucose sensor is implanted subcutaneously in the abdomen 
[30]. This sensor continuously measures glucose levels and sends the blood glucose 
levels to an external monitor [30]. The monitor then alerts the user if their blood glucose 
levels are out of the healthy range [30]. SMBG devices only provide a single blood 
glucose reading for each test; however, CGM devices continually measure blood glucose 
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levels [30]. Continuously measuring blood glucose levels allows patients and physicians 
to detect trends. These trends can be used to determine the optimal time and amount of 
insulin to administer [3]. Although this device allows the user not to worry about 
adhering to a strict testing schedule, there are several downsides to this device. The 
patient must have the glucose sensor internally implanted and live with an implanted 
device. CGM devices also require calibration every 12 hours, but it is recommended that 
the device be calibrated three to four times a day [30]. This calibration requires the user 
to use a SMBG device to collect and test a blood sample, so the patient is still subjected 
to the pain of a fingerpick [30]. Although this technology is very expensive, most 
insurance companies will either cover or reimburse CGM devices, so cost is usually not 
an issue with this type of device.  
The most accurate method of testing blood glucose levels is a blood test at a physician’s 
office. Bloodwork is not an option for managing diabetes, as the results are not available 
quickly enough for diabetics to correct blood glucose levels. This is also very expensive, 
requiring the diabetic to pay to be seen by a physician and to have bloodwork performed. 
In addition, having blood drawn is painful and invasive. 
Currently, there is a lot of research in alternative diabetes monitoring devices. The 
TearTOUCH device is a blood glucose monitoring device that utilizes tear fluid instead 
of blood [11]. This device consists of polydimethylsiloxane (PMDS) microfluidic 
attached to a screen-printed electrode [4]. A current is produced when the tear fluidic 
reacts with the liquid reagents in the device. These reagents include a mixture of glucose 
dehydrogenase flavin adenine dinucleotide (GDH-FAD), phosphate buffered saline, and 
potassium ferricyanide [4]. The research on this device determined the correlation 
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between tear fluid glucose levels and blood glucose levels, proving the tear fluid could be 
a viable alternative to blood [3]. The current produced from the reaction is proportional to 
the glucose concentration of the sample. This device provides an alternative to the painful 
fingerpicks associate with SMBG and CGM devices [3]. The TearTOUCH device is not 
yet ready for the market, as there are still multiple factors that must be addressed before 
the device is ready for consumers. The liquid reagents must be dried down so that the 
devices can be used outside of the lab and has a shelf life comparable to SMBG test 
strips. A drying technique has been developed but still requires animal and human 
testing. The TearTOUCH device also needs to be redesigned so that the required tear 
sample size can be smaller and more realistic for the tear volume contained in the average 
human eye. Although the TearTOUCH device has been tested in rabbits, this technology 
has not yet been tested on humans.  
A tattoo-based glucose monitoring device is also being developed [2]. This flexible, peel-
and-stick tattoo for the arm uses the capillary fluid to determine blood glucose levels [2]. 
A secondary device is used to report the blood glucose levels measured from the device 
using reverse iontophoretic extraction of glucose in the interstitial fluid [2]. This proof-
of-concept device was tested in several human subjects. The blood glucose levels from 
the biosensing tattoo were compared to results from a commercially available SMBG 
device, ultimately supporting the data that this technology is possible. This device could 
be a pain free alternative to SMBG and CGM devices but requires a lot of research and 
development before its introduction on the market.  
There are also advances in the development of an ophthalmic lens to measure blood 
glucose levels. This device contains a loop antenna, a communication chip, and a 
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polymer substrate glucose sensor [15]. The glucose levels in the tear fluid are correlated 
to blood glucose levels and is reported to a device that the user can see [15]. Although 
this provides an alternative to current blood glucose monitoring devices, this device has 
not been tested in animal or human subjects. All testing of this device was conducted on a 
polydimethylsiloxane eye model under optimal conditions, so it is still unclear how this 
device would perform in non-ideal conditions, such as in a patient with dry eyes.  
 
Electrochemistry Overview 
Electrochemistry is the study of chemical reactions that result in electron movement. A 
common example in which this is found is the concept of oxidation-reduction reactions, 
also known as redox reactions. These reactions are based upon a coupled event where 
there is a loss of an electron on a molecule by oxidation, and a gain of an electron on a 
molecule by reduction. Many of these processes occur naturally, such as the green plant 
photosynthesis and the biochemistry involved with converting food into an energy source 
for the body. Each involves the transfer of electrons and have played a critical role in 
nature for millions of years. A simple redox reaction can be seen in the production of 
NaCl, commonly known as table salt, by utilizing the following stoichiometricly 
balanced equation: 
2 Na0 + Cl2 à 2 NaCl 
The positively charged sodium atom promotes the acceptance of electrons whereas the 
negatively charged chlorine atom promotes the loss of an electron. In order to show the 
electron movement, the equation reaction above can be broken down further by the 
respective atoms: 
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Oxidation:     Na0 à Na+ + e- 
Reduction:     Cl2 + 2 e- à 2 Cl- 
This relationship is based upon creating equilibrium through bonds to achieve the greatest 
amount of stability between the two atoms. The transfer of electrons caters to the ability 
of creating equilibrium states for molecules through the inherently coupled events of 
oxidation-reduction reactions [24]. By taking the concept of electron movement for redox 
reactions and applying it to the field of physics, chemistry can be used to look at a similar 
reaction performed through a conductive electrical wire that creates an electrochemical 
change [24]. This is the fundamental concept that is used in the study of electrochemistry 
and can be seen throughout various commonly used items. Batteries utilize the changes in 
electron flow from redox reactions to create electrical energy and provide the power for 
almost all portable electronics. Electrical laboratory measuring equipment allows for 
monitoring of chemical reactions [24]. Industry utilizes electrochemistry to produce 
important chemicals, such as those in liquid bleach [24]. The possibilities of applications 
for electrochemistry are boundless, with various techniques and branches that permit new 
advances in technology and healthcare [24]. Such techniques will be explored throughout 
this section in order to provide reasoning for utilizing such methodology and illustrate its 
importance to scientific study.  
Electrochemistry can be broken up into two fundamental fields – potentiometry and 
amperometry. Potentiometry is the measurement of the voltage between two electrodes, 
while amperometry is the measurement of current between two electrodes [8]. An 
application that can be utilized to test both of these measurements within 
electrochemistry is through the creation of an electrochemical cell. The electrochemical 
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cell is an electrical circuit composed of two half-cells, one cell a cathode and the other an 
anode, immersed in respective ion solutions, with a salt bridge connecting the two 
electrodes. The salt bridge, commonly KCl, allows the electrons to flow freely across ion 
solutions, completing the circuit. The following Figure showcases a typical 
electrochemical cell along with the redox reaction equilibrium equation for the respective 
electrodes: 
 
Figure 1: A commonly used electrochemical cell and the redox reaction 
performed. 
 
 The cathode and anode electrodes play important roles that follow the conventions of 
redox reactions. The cathode is reduced where the anode is oxidized, a permissible event 
by the use of the salt bridge [17]. Each reaction of oxidation or reduction has an 
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associated change in energy produced by the electron flow that is dependent on the 
material used. This change in energy is known as the electrode potential and can be used 
to determine the total amount of energy potential of an electrochemical cell at standard-
state (performed under standard conditions of 1 mole per liter (1 M) and pressure of 1 
atmosphere (1 atm) at 25oC) by utilizing the Nernst Equation [17]. This equation is 
defined as: 
Ecell = Ec – Ea 
Where Ec and Ea are the reduction potentials for the electrode redox reactions which both 
follow an equation to achieve determination of respective reduction potentials under 
standard-state: 
𝑬 = 𝑬𝟎 −	𝑹𝑻𝒏𝑭 𝐥𝐧	(𝑸) 
𝑬 = 𝑬𝟎 −	𝟎. 𝟎𝟓𝟗𝟏𝟔𝒏 𝐥𝐨𝐠	(𝑸) 
Where E is the reduction potential of the respective electrode, Eo is the standard-state 
reduction potential, n is the number of electrons in the redox reaction and Q is the 
reaction quotient of the electrode. The reduction potential of the entire system can be 
calculated based upon such standard-state values but can also be found utilizing methods 
of potentiometry. This involves using a potentiometer connecting the two electrodes 
together to measure the change in the reduction potentials caused by electron flow in the 
redox reductions [17]. This method of connection between the two electrodes is also 
useful in amperometry to find the rate of electron flow known as current.  The current 
between the two electrodes can be determined using an ammeter [8]. The applications of 
potentiometry and amperometry are critical to understand so that measurements within 
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systems can be monitored and used to provide accurate scientific results. As shown with 
an electrochemical cell, natural systems with qualitative electron flow characteristics can 
now be quantified and measured objectively to provide insight on how the system 
functions. The fundamental principles of both fields can be used to proceed with further 
in-depth analysis of various systems, not just limited to electrochemical cells, by way of 
modified techniques. Cyclic voltammetry (CV) is a type of potentiometry 
electrochemical measurement that utilizes oscillating low to high voltages on an electrode 
to obtain analytical, thermodynamic, kinetic, and mechanistic information about chemical 
systems involving redox reactions [8]. Such measurements include concentration, redox 
potentials, equilibrium constants, or rate constants for reactions involving 
electrogenerated species [8]. Understanding of how cyclic voltammetry works can be 
described within the electrochemical cell system and the governing electrical reduction 
potential equations [20]. Cyclic voltammetry utilizes low and high voltage sweeps that 
are predicted by the Nernst Equation for cathode and anode reduction potentials. The 
constant voltage sweep is applied to a working electrode that is connected to a reference 
(grounded) electrode to produce a resulting current [16]. This current is measured as a 
function of potential which is known as a voltammetry experiment, commonly performed 
in electroanalytical chemistry [20]. In terms of usefulness, this relationship can help in 
comparison between the effectiveness of various materials and their possible applications 
based on resulting voltage vs. current measurements. In addition, by knowing the 
variables within the Nernst Equation, concentration, reduction potentials, and the number 
of electrons per molecule of analyte oxidized or reduced can be found which may provide 
useful information for experimental significance [20]. 
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Similar in methodology to cyclic voltammetry, an amperometric i-t test is a type of 
amperometry electrochemical measurement that uses the resulting current from the cyclic 
voltammetry test and is measured against time. This generates a current vs. time plot that 
can assist in determining various information about the materials and mediums used 
within the chemical system [18]. A direct form of application is through Fick’s first law 
of diffusion to determine diffusion rates based upon concentration differences over time 
[18]. This ability to determine diffusion rates by a simple experiment aids in the 
effectiveness of using such an experiment and its potential to quantize characteristics of 
the experimental system [18]. 
Electrochemistry is a fundamental branch of chemistry that incorporates various concepts 
of physics to quantitatively characterize and determine properties of a given chemical 
system under analysis [18]. The core chemistry concept of oxidation-reduction reactions 
allows for two branches, voltammetry and amperometry, to be created that create a 
methodology for studying a system through measurements of its electrical potentials and 
electron flow [18]. Cyclic voltammetry, used in conjunction with an electrochemical cell, 
provides information regarding the current (flow of electrons) through the system during 
application of oscillating voltages [18]. Amperometric i-t tests can be created from the 
resulting cyclic voltammetry current when measured against time. Independently, this 
data provides only basic information regarding the physics behind the experimental 
system [18]. When conjoined and applied to the Nernst Equation, Fick’s Law of 
diffusion, and Faraday’s Law, a whole host of system characteristics can be quantitatively 
described to give insight on how the component composition of the chemical system can 
be applied to other areas. Electroanalytical chemistry techniques are used to obtain 
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analytical, thermodynamic, kinetic, and mechanistic information [18]. From one single 
voltammetry experiment, quantitative data regarding concentration, redox potentials, 
equilibrium constants, rate constants for reactions involving electrogenerated species, 
diffusion rates, diffusion coefficients, and number of electrons per molecule of analyte 
oxidized or reduced can be calculated. This information is essential towards 
advancements in science and technology to facilitate the creation of new material 
coatings, implantable devices, more efficient batteries, and more efficient, effective, and 
affordable diabetes glucose sensor strips. Glucose sensors strips utilize the concept of 
electrochemistry with every measurement obtained. Therefore, by utilizing techniques of 
voltammetry and amperometry, research into the possibilities of finding new methods or 
materials for creating glucose strips through experimentation can ultimately lead to 
providing a more affordable and comfortable way of life for diabetics globally.  
 
Glucose Biosensors 
There are three main parts of a biosensor. The first part is the biological recognition 
element [13]. In a glucose monitoring biosensor, this is the enzyme that reacts with 
glucose [13]. A common enzyme is glucose dehydrogenase flavin adenine dinucleotide 
(GDH-FAD). The second part of a biosensor is the transducer [13]. The transducer 
converts the transfer of electrons into current output [13]. The third part of a biosensor is 
a processing system [13]. The processing system transforms the current output to the 
glucose output reading. This processing is important as it allows the user to receive 
results that are easily interpretable.   
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There are three generations of glucose monitoring biosensors [12]. The first generation 
use oxygen as the final electron acceptor [12]. These devices usually contain glucose 
oxidase enzyme to catalyze the reaction. This enzyme is highly specific to glucose and 
can withstand a wide range of pH readings and temperatures; however, glucose oxidase 
can react with oxygen [7]. These devices can easily produce inaccurate results, as oxygen 
from the surroundings can affect the glucose output levels of these devices [12]. Many 
SMBG devices are considered a first-generation device. Second-generation glucose 
biosensors have an artificial electron acceptor that serves as the final electron acceptor 
[12]. This artificial acceptor is referred to as a redox mediator or a redox probe. 
Potassium ferricyanide is a typical redox mediator. GDH-FAD is a common enzyme in 
second generation devices and does not react with oxygen but can react with sugars in the 
body other than glucose. Although these devices eliminate possible errors from oxygen, 
the redox mediators are typically toxic [12]. In third-generation glucose biosensors, the 
electrode surface serves as the final electron acceptor [12]. These devices eliminate the 
toxic redox mediator and possible errors from oxygen [12]. 
Below is the reaction that is occurring in the proposed glucose monitoring biosensor. In 
reaction (1), the glucose reacts with the GDH-FAD enzyme. In this reaction, the glucose 
is oxidized and the GDH-FAD enzyme is reduced. In reaction (2), the reduced GDH-
FAD enzyme from reaction (1) then reacts with the redox mediator, which is potassium 
ferricyanide ([Fe(CN)6]3-). The GDH-FAD enzyme is oxidized back to its original form, 
while the redox mediator is reduced. In reaction (3), the redox mediator reacts with the 
surface of the electrode. The reduced redox mediator is oxidized to its original form 
while the sensor is reduced.  
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(1) Glucose + GDH-FAD à Glucono-1,5-lactone + GDH-FADH2 
(2) GDH-FADH2 + [Fe(CN)6]3-à GDH-FAD + [Fe(CN)6]4- 
(3) [Fe(CN)6]4- + Sensor à [Fe(CN)6]3- + Sensor (reduced) 
The three reactions show the movement of electrons. The electron is passed from the 
glucose molecule, to the enzyme, to the redox mediator, and then finally to the sensor. 
The electron is then allowed to move through the electrode where the current is 
measured. The current is proportional to the concentration of glucose molecules which 
can be utilized for monitoring glucose levels. 
 
3D-Printing Overview  
Additive manufacturing is the technique of building objects by layering material [1]. 3D 
printing is one of the most popular forms of additive manufacturing. In 3D printing, a 
computer aided design (CAD) file of the object is created on a software program [28]. 
There are software programs that allow for very technical designs, such as SolidWorks; 
however, there are more intuitive design programs, such as Tinkercad, that sacrifice 
technical details in exchange for simplicity while still maintaining overall functionality. 
The CAD file is then transferred to the 3D printer software, where the print can begin. 
The designed object is created by adding layers of heated substrate material on top of 
each other [29]. The additive substrate material, including various types of plastics, 
metals, waxes, carbons, and even biomaterials, creates density for which the object of 
interest is specified [29]. 
Although 3D printing has been around since the early 1980s, it has grown recently in 
popularity due to the development of low-cost 3D printers [26].  More user-friendly 
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software has allowed people to come up with unique applications for 3D printers. This 
ultimately transformed the industry from an expensive method to develop trinkets, into a 
more inexpensive means to develop healthcare and industrial goods. The options for 
substrate materials has expanded, allowing for more application of 3D printed objects. 3D 
printing also has many distinct benefits when compared to traditional manufacturing [29]. 
Objects that are 3D printed can be customized much more easily [29]. The amount of 
time to build an object from a conceptual design is much shorter when compared to 
traditional manufacturing processes [29]. This proves beneficial not only to prototyping 
but also to companies trying to get products on the market more quickly. In addition, 3D 
printing not only simplifies the manufacturing process, but it also reduces wasted 
materials, contributing to its overall cost effectiveness [29]. 
Currently, the four main market areas utilizing 3D printing include: aerospace, industrial, 
healthcare, and automotive industries [29]. The current applications of 3D printed parts 
include: automotive engine components, consumer sporting goods, orthodontic implants, 
and surgical guides [29]. The 3D printing industry is drastically growing and is projected 
to be over a $17 billion market by 2020 [29]. It is also projected that stents and 
prosthetics will soon be added to the list of 3D printed healthcare items and marketed to 
patients [29]. Research is currently being conducted to bio-print organs and body parts 
using living cells as the substrate material [28]. The use of 3D printing in the medical 
field will allow for more personalized care that will improve outcomes for patients [26]. 
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CHAPTER 2 
METHODOLOGY 
Creating the CAD Model of the 3D Printed Sensor 
The first step in the development of the 3D printed glucose sensor was designing the 
sensor in SolidWorks. This sensor was designed to have similar dimensions and features 
to Zensor TE100 SPEs (Zensor, Taiwan).  The final SolidWorks model of the 3D printed 
sensor is seen below in Figure 2.  
 
Figure 2:  SolidWorks model of sensor.  
 
3D Printing the Sensor 
The SolidWorks file was opened and saved as a STL/object file. A conductive filament 
was required to create this sensor. The conductive graphene PLA filament, purchased 
through BlackMagic3D, was determined to be the most conductive filament available. 
The MakerBot printer was selected to create this sensor as it is specifically designed to 
print PLA filament. This sensor file was then imported into the MakerBot Print software. 
The sensor model was then rotated 90 degrees along the x-axis, so that the sensor was 
arranged properly on the build plate. The sensors on the build plate can be seen below in 
Figure 3. 
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Figure 3: Sensor models on MakerBot build plate.  
 
To adjust the print settings, the custom settings button was selected. The temperature 
settings for the extruder were changed to 220 C, as this was determined to be the melting 
point for the conductive graphene filament. The infill density was selected to be 100% to 
create a solid print and maximize the conductivity of the sensor. The travel speed was 
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changed to 30 mm/s, as this was determined to produce a print with the highest resolution 
and prevent slipping. The retraction distance was also adjusted from 0.5mm to 1.5mm. 
This change was important to prevent the filament from oozing out of the extruder 
between layers. The final printer settings can be seen below in Figure 4.  
 
Figure 4: Final settings for using conductive graphene filament on MakerBot printer.  
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Once these settings were selected and the sensors were arranged on the build plate, the 
print file was exported to the 3D printer. The filament was then loaded into the printer 
and the mylar substrate was taped onto the platform. Taping the mylar substrate was 
determined to be critical to ensure that no warping occurred during the print. The file was 
then selected on the printer and the print was started.  
 
 
Chemicals 
All the chemicals used in experiments were purchased through Sigma-Aldrich unless 
stated otherwise. The enzyme used in these experiments, glucose dehydrogenase flavin 
adenine dinucleotide (GDH-FAD), was donated from Amano Inc. (Japan). The GDH-
FAD used had an activity of 209 units/mg. Phosphate-buffered saline (PBS), with a pH of 
7.4, was used to prepare all glucose solutions, the redox probe solution, and enzyme 
solution.  
 
Making Redox Probe Solution 
To test the electrochemical properties of the sensor, the reagent mixture was first created. 
This mixture consists of enzyme and a redox probe. To create the redox probe, potassium 
ferricyanide and phosphate buffered saline were mixed together to form a solution with a 
concentration of 100mM. The mixture was stored in an amber vial as the mixture is light 
sensitive. This redox probe solution was mixed using a vortexer for 30 seconds and then 
allowed to sit for ten minutes. After ten minutes, the redox probe mixture was tested to 
ensure that it was made correctly.  
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To test the redox probe, the CHI 1230A (CH Instruments, Austin, TX) was checked to 
ensure that the hardware was working correctly. Results of a successful hardware test can 
be seen below in Figure 5.  
 
Figure 5: Results of successful hardware test on CHI 1230A. 
 
A Zensor was then hooked up to the CHI 1230A using alligator clips. The red alligator 
clip was attached to the counter lead of the electrode. The green alligator clip was 
attached to the working lead of the electrode. The reference lead was then attached to the 
white alligator clip. The technique on the CHI 1230A machine was selected to be cyclic 
voltammetry. The parameters were set to have a voltage between -1V and 1V. The rest of 
the parameters are seen below in Figure 6.  
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Figure 6: Parameters for running cyclic voltammetry to test redox probe. 
 
Once the parameters were set, 90uL of the redox probe mixture was pipetted onto the 
working circle of the Zensor and the run button was selected. Once the CHI 1230A 
machine was done running, a current verse potential graph was produced. A successful 
redox probe mixture could be confirmed if the graph resembled the shape and magnitude 
of that in Figure 7.  If the graph did not resemble Figure 7, the redox probe mixture was 
disposed of and remade.  
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Figure 7: Successful cyclic voltammetry test to verify redox probe solution.  
 
Making Enzyme Solution 
To create the enzyme solution, GHD-FAD and the 100mM redox probe solution was 
mixed together in a one-to-one ratio, 1 mg of the GHD-FAD enzyme was mixed with 1 
mL of the redox probe solution. This solution was created and stored in a light sensitive 
amber vial. It was lightly mixed, but not mixed using the vortexer. This is because the 
enzyme could be denatured by vortexing. Before using the enzyme solution, it was 
allowed to fully dissolve for ten minutes.   
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Making Glucose Solutions 
Glucose solutions of various concentrations were prepared using PBS. The 
concentrations of glucose solutions that were prepared included: 0, 25, 50, 100, 200, and 
400 mg/dL. A vortexer was used to mix the glucose and PBS. The solutions were 
prepared 24 hours prior to their use. This allowed the glucose to fully dissolve.  
 
Determining Optimal Settings to Test 3D Printed Sensor 
To determine the proper parameters for testing, cyclic voltammetry tests were conducted 
with control leads. The reference electrode lead was replaced by an Ag/AgCO wire. The 
working electrode lead remained on the 3D printed sensor. The counter electrode lead 
was replaced by a platinum wire. These leads were placed into a small beaker and 
alligator clipped to the CHI 1230A machine. Redox probe solutions at various 
concentrations were added to the beaker and data was collected. The voltage range was 
also changed to determine the optimal voltages. The set-up of this experiment is seen 
below in Figure 8.  
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Figure 8: Set up of experiment to determine test parameters using control leads.  
 
Testing 3D Printed Sensor 
The 3D printed sensors were separated and cut apart. The sensors were cut so that 
minimal mylar was surrounding the leads. The leads were attached to the CHI 1230A 
machine, so that the red alligator clip was attached to the counter lead, the green alligator 
clip was attached to the working lead, and the white alligator clip was attached to the 
reference lead. The technique was selected to be amperometric i-t. The parameters were 
selected to that the initial voltage was 0.35V. The run time was selected to be 90 seconds 
for all the tests to ensure that enough data was collected to capture all trends. The rest of 
the parameters are seen below in Figure 9.  
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Figure 9: Parameters for running amperometric i-t test to test 3D-printed sensor. 
 
Once the CHI 1230A machine was set up, 810uL of the enzyme solution was pipetted to 
into a testing vial. Then, 90uL of the glucose solution was pipetted into the vial. This 
mixture was stirred 10 times counterclockwise. The 3D printer attached to the CHI 
1230A machine was then dipped into a testing vial and the test was immediately started.  
The set-up of this test is seen below in Figure 10.  
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Figure 10: 3D printed sensor in testing vial.  
 
A current verses time graph was produced and all the data was saved in both a text file 
and an Excel file.  The data was then analyzed in Excel.  
 
Overview of Sensor  
Figure 11A shows the CAD model of the 3D-printed sensor, while Figure11B shows the 
sensor printed onto the mylar substrate. The current output from the sensor is a reaction 
between GDH-FAD and glucose solutions of various concentrations. This can be seen 
below in Figure 11C.  
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Figure 11: A) A CAD model of the 3D printed sensor with dimensions 11.07x37.72x0.95 
mm. B) Sensor printed with conductive graphene filament onto a mylar substrate. C) The 
reaction of the glucose and glucose dehydrogenase reacting generating electrons that are 
converted to a current output. 
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CHAPTER 3 
RESULTS AND DISCUSSION 
Development of the CAD Model of the 3D-Printed Sensor 
A three-lead electrode was designed in SolidWorks, as seen in Figure 12 and Figure 13. 
The three-lead design was used because it is an industry standard and allows for a 
counter, working, and reference lead. This CAD model was designed to have the leads 
and substrate printed together.  
 
Figure 12: Original SolidWorks design of 3D-printed sensor. 
5HJXODU$VVHPEO\
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Figure 13: Original SolidWorks design of 3D-printed sensor with dimensions.  
 
This design did not prove acceptable for several reasons. It required two extruders for 
printing, which resulted in many wasted sensors from calibration issues.  In addition, all 
the amperometric i-t tests performed on these sensors were highly variable and produced 
very low current outputs. The physical sensor can be seen below in Figure 14.  
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Figure 14: Sensor with 3D-printed leads and substrate. 
 
Development of the Updated CAD Model of the 3D-Printed Sensor 
An updated SolidWorks model, seen below in Figure 15 and Figure 16, was created to 
more closely resemble the structure, dimensions, and design of the industry standard, 
Zensor. Both the 3D printed sensor and Zensor have a three-lead design with a 3mm 
working diameter. This was important to allow data output between the two sensors to be 
more easily comparable. In this design, the substrate was not printed. Instead, the sensor 
was designed to be printed onto a mylar substrate that was secured to the printing 
platform of the printer.  
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Figure 15: Updated CAD model of sensor. 
 
 
Figure 16: Updated CAD model of sensor with dimensions. 
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Test Print of CAD Model of 3D-Printed Sensor  
With the updated CAD model, a test print was conducted to see if the printer resolution 
was small enough for the details of the sensor and if the sensor could be printed onto the 
mylar substrate. For this print, a blue ABS filament (Adafruit, USA) was used in the 
MakerGear Printer. This filament was chosen because it is a common printing filament 
that was readily available for this test print. As seen below in Figure 17, the printer 
successfully printed the sensor onto the substrate with high resolution; however, the 
printed sensor was not conductive. The resistance of the working electrode was 
determined to be on the order of hundreds of mega ohms for three centimeters of 
filament, meaning that the filament was nonconductive.  Filament with such a high 
resistance would not allow electrons to move freely through the sensor, so it was 
determined that a more conductive filament was necessary.  
 
Figure 17: Test print with blue ABS filament to verify that the sensor can be printed.  
 
Development of Alpha Prototype of 3D-Printed Sensor  
The Octave ABS filament (Octave, USA) was determined to be more conductive with a 
preprinted resistance of about 37 MW for three centimeters. The updated CAD file was 
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printed using the MakerGear printer. The printed sensor can be seen below in Figure 18. 
The print quality was still reasonably good and provided a printed resistance of around 30 
MW for the length of the working electrode. Although this resistance was lower than the 
previously 3D printed sensors, the resistance was still too high for an electrochemical 
sensor. The resistance of the Zensor’s working lead is about 100 W, so the 3D-printed 
electrode had to have a filament that was similar. 
 
Figure 18: Alpha prototype of 3D-printed sensor made from Octave ABS filament.  
 
Development of Beta Prototype of 3D-Printed Sensor 
To increase the electrochemical properties of the sensor, an ABS conductive black 
filament (Black Magic 3D, USA) was purchased. This filament was advertised to be 
conductive with a preprinted resistance on the order of kilo ohms; however, it was 
determined that the preprinted resistance was approximately 20 MW per three 
centimeters. The difference in resistivity could be due to manufacturing impurities or 
errors, as this filament is no longer sold by Black Magic. The updated CAD model was 
printed using this filament on the MakerGear printer. Although optimal printer settings 
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had to be determined once again, printing the ABS conductive black filament with carbon 
still proved to be challenging. The retraction settings of the printer were increased to the 
maximum level to reduce the bleeding of the leads. The extruder head temperature was 
increased to 220°C - which was critical for the filament not to clog the extruder head - 
and the platform temperature was increased to 55°C. These changes prevented the printer 
from etching the sensor into the mylar substrate and not extruding out filament. The 
resolution of the 3D-printed sensor with this filament was not ideal, so after each print, a 
razor was used to clean up the areas of the leads that had bled together. The beta 
prototype of the sensor printed with the ABS conductive black filament can be seen 
below in Figure 19. 
 
Figure 19: Beta prototype of 3D-printed sensor printed using ABS conductive black 
filament. 
 
The printed resistance of the working lead of this electrode was determined to be 
approximately 22 MW. Due to a somewhat smaller resistance compared to the previous 
3D printed sensors, the electrochemical properties of this sensor were tested. The current 
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output at various glucose concentrations was measured for the 3D printed sensor and 
compared to the Zensor. The current outputs for the 3D-printed sensor and the Zensor 
were compared because it was determined to be a comparable device on the market. The 
3D printed sensor produced current output values that were two to three orders of 
magnitude less than the Zensor current output values. This demonstrated that the 
resistance was still too high for the electrical sensor. The R-squared value for this data 
was determined to be very low at 0.01, as seen in Figure 18. The inconsistencies of the 
physical characteristics of the printed sensors were determined to be the cause for the 
extremely low R-squared value. The inconsistencies included differences in porosity, 
mass, and density of the filament between the 3D printed sensors. The data from Figure 
20 showed that a more conductive filament and a printer with a higher resolution was 
required. 
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Figure 20: Current verses glucose solutions of various glucose concentrations for sensor 
printed with conductive black filament. 
 
Development of Gamma Prototype of 3D-Printed Sensor 
A conductive graphene filament was ordered (Black Magic 3D, USA), with a preprint 
resistivity of 1.8 W per three centimeters. Graphene was determined to be a good material 
as it is strong, flexible, and conductive. This filament is a PLA based filament, so a 
printer specifically designed for PLA filaments was used to increase the resolution and 
quality of the print. The print settings for this can be found in the methods section. 
Determining these settings was critical as the graphene in the filament proved to be 
challenging to print with. Even with the optimal setting for the print, the sensors still had 
some inconsistencies that could be visually observed. To control for these 
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inconsistencies, a razor was used to thoroughly and precisely clean filament that had bled 
between the three leads. After the sensor was printed, the working lead of the electrode 
was determined to have a resistivity of approximately 700 W. This was much more 
comparable to the Zensor’s resistivity of approximately 100 W. The sensor printed using 
the conductive graphene filament can be seen below in Figure 21.  
 
Figure 21: Gamma prototype of 3D-printed sensor made from conductive graphene 
filament onto a mylar substrate. 
 
Calibration of Gamma Prototype of 3D-Printed Electrode  
Before testing could be conducted on the conductive graphene 3D-printed sensors, the 
specific testing parameters had to be determined. The electrochemical analyzer CV was 
performed using various concentrations of redox probe at various voltages to determine 
the suitable parameters for amperometric i-t testing. The parameters were selected to 
have the best signal-to-noise ratio (SNR). A bias potential of 0.35V was selected, as seen 
in Figure 22.  
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Figure 22: Shows a CV using a Zensor with redox probe. The red circle shows the most 
optimal current responses observed in amperometric i-t  is at 0.35V. 
 
Using this voltage, the various glucose solutions were tested using amperometric i-t. An 
analysis determined that the electrical current at 42.3 seconds was the best representation 
of the signal produced by the sample, as shown in Figure 23A. At this time, the electrical 
current output had the highest correlation and slope. Current values at 42.3 seconds were 
used in the construction of calibration curves. 
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Figure 23: A) A representation of the highest slope and R2 at the most optimal time point. 
B) The peal representation of the R2 versus the slope. 
 
Initial Verification of Gamma Prototype of 3D-Printed Sensor  
With a 3D printed sensor with a resistivity comparable to the Zensor and the ideal testing 
parameters, an amperometric i-t test was performed. The current output was measured for 
glucose solutions of various concentrations. The results from this data showed that there 
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was a positive relationship between the measured current output and the glucose 
concentration; however, the current differences between the various glucose 
concentrations were very low. This can be seen below in Figures 24 through 26. This data 
was further analyzed for the current output at 42.3 seconds. The results can be seen in 
Figures 27 through 30. Sensor 1 was determined to have an R-squared correlation value 
of 0.75 and a slope of 4.70E-13x with representing the concentration of glucose and the 
y-intercept being -2.50E-05 Amps. Sensor 2 was determined to have an R-squared 
correlation value of 0.86 and a slope of 8.89E-13x with representing the concentration of 
glucose and the y-intercept being -2.50E-05 Amps. Sensor 3 was determined to have an 
R-squared correlation value of 0.79 and a slope of 1.51E-08x with representing the 
concentration of glucose and the y-intercept being -2.29E-05 Amps. The average of 
sensors 1, 2, and 3 was determined to have an R-squared correlation value of 0.79 and a 
slope of 5.02E-09x with representing the concentration of glucose and the y-intercept 
being -2.43E-05 Amps. This supported that the 3D printed graphene sensors were 
accurately detecting the various glucose solutions. 
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Figure 24: Current versus time for sensor 1 showing the expected trend for various 
glucose solution concentrations.  
 
Figure 25: Current versus time for sensor 2 showing the expected trend for various 
glucose solution concentrations. 
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Figure 26: Current versus time for sensor 3 showing somewhat of the expected trend for 
various glucose solution concentrations. This trend was not as consistent as the other 
sensors. 
 
 
Figure 27: Current verses glucose solutions of various concentrations for sensor #1, 
which was printed with conductive graphene filament. 
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Figure 28: Current verses glucose solutions of various concentrations for sensor #2, 
which was printed with conductive graphene filament. 
 
Figure 29: Current verses glucose solutions of various concentrations for sensor #3, 
which was printed with conductive graphene filament. 
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Figure 30: Average of the current verses glucose solutions of various concentrations for 
sensors 1, 2, and 3, which were printed with conductive graphene filament. 
 
Post Print Modification of 3D-Printed Sensor 
It was hypothesized that the low signal difference between glucose concentrations was 
because the redox probe mixture was not reacting properly with the graphene filament 
due to the inconsistency of the print quality. Although the printed sensors appeared to be 
similar, there were differences in the density and porosity of the filament. To correct for 
this, the sensors were soaked in enzyme solution containing potassium ferricyanide for 
420 minutes while in the refrigerator, as seen below in Figure 31.  
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Figure 31: This illustration shows the soaking procedure of the 3D printed graphene 
sensors. The procedure required using 100 mM concentration of ferri and 209 units/mg 
concentration of enzyme. 
 
To determine how long the 3D-printed sensors needed to soak in the enzyme solution, 
sensors were soaked for various lengths of time. The times that were tested included: 0 
minutes, 15 minutes, 30 minutes, 45 minutes, 60 minutes, and 420 minutes. While the 
sensors were soaking in the enzyme solution, they were stored at 277.15K due to the 
temperature sensitivity of the GDH-FAD enzyme. The results from this can be seen in 
Figure 32. A soak time of 60 minutes was determined not to be enough time, as the R2 
value was determined only to be 0.11. Of the soak times tested, 420 minutes produced the 
best results, as the R2 value was determined to be 0.92. The R2 value for the 420-minute 
soak time was comparable to the R2 value of the Zensor, which was determined to be 
0.99. Soaking the electrodes allowed for the enzyme solution to fill in the pores of the 
printed sensor, which allowed for easier movement of electrons through the working 
sensor, resulting in an increase in the current output. 
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Figure 32: A) Shows the effects of a soak time of 0, 15, 30, 45, 60, 420 minutes on the 
slope and linear correlation values. B) This shows an overlay plot of the current with soak 
times of 60 and 420 minutes. The current output for glucose solutions of various 
concentrations for each individual soak time were overlaid with a Zensor to show that 
420 minutes gave the best comparable result when compared with a Zensor. Soak time 
below 60 minutes produced a flat line when graphed alongside the scale. Additionally, 
the magnitude of slope increased with increasing soak time. 
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Quality Control of 3D-Printed Sensor  
The electrodes were printed and prepared in batches of nine. The baseline current output 
readings were compared and the sensors were placed into batches. These batches 
contained sensors that produced similar baseline current output readings. Placing sensors 
into batches according to baseline readings is a standard procedure in the SMBG device 
industry.  
 
Verification of Soaked Gamma Prototype of 3D-Printed Sensor 
The current output for the soaked 3D-printed sensors were compared and calibration 
curves were created. Although 42.3 seconds was determined to be the optimal current 
output time, calibration curves were also created for 3 seconds and 13 seconds. These 
times were selected to generate a more reasonable range comparable for SMBG devices 
when compared to the optimal experimental current output time. As seen in Figure 33C, 
the calibration curve for 42.3 seconds was determined to have an R-squared correlation 
value of 0.97, a slope of -3.14E-09x (with x representing the concentration of the glucose 
solution), and a y-intercept of -3.45E-07 Amps. As seen in Figure 33B, the calibration 
curve for 13 seconds was determined to have an R-squared correlation value of 0.94, a 
slope of -3.20E-09x (with x representing the concentration of the glucose solution), and a 
y-intercept of -4.16E-07 Amps. As seen in Figure 33A, the calibration curve for 3 
seconds was determined to have an R-squared correlation value of 0.80, a slope of -
3.50E-09x (with x representing the concentration of the glucose solution), and a y-
intercept of -6.44E-07 Amps. 
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Figure 33: A) This is a representation of the 3D printed strip sensor calibration curve with 
glucose solutions based off current readings at 3 seconds (N = 4). B) This is a 
representation of the 3D printed strip sensor calibration curve with glucose solutions 
based off current readings at 13 seconds (N = 4). C) This is a representation of the 3D 
printed strip sensor calibration curve with glucose solutions based off current readings at 
the optimal time of 42.3 seconds (N = 4). Error bars shown for all figures are standard 
error. D) Normal probability plot of residuals versus the glucose concentrations at time of 
3 seconds. E) Normal probability plot of residuals versus the glucose concentrations at 
time of 13 seconds. F) Normal probability plot of residuals versus the glucose 
concentrations at time of 42.3 seconds. We can see in the residual plots that after 13 
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seconds, there is no obvious pattern when plotting the residual vs the run order, which 
would be evident of a good model. 
 
The calibration curve at a time of 13 seconds is significantly better than the calibration 
curve at a time of 3 seconds. Although the calibration curve at 42.3 seconds is slightly 
better than the calibration curve at 13 seconds, the improvements are negligible. This 
means that the current outputs after 13 seconds are just as reliable as the current outputs 
at the optimal time of 42.3 seconds.  
To determine if the calibration curves fit the data well, the residuals were plotted for the 
three current output times. These results can be seen above in Figure 33. As shown in 
Figure 33D, it was determined that the calibration curve at a time of 3 seconds did not fit 
the data well, as the residuals were not random and a pattern could be observed. As 
shown in Figure 33E, it was determined that the calibration curve at a time of 13 seconds 
did fit the data well, as the residuals were random and had a relatively constant spread, 
allowing a linear regression model to be used. The calibration curve at a time of 42.3 
seconds was also determined to be a good fit to the data, as seen in Figure 33F. Figure 
33F shows that the residuals do not have a visible pattern and were not spread unevenly. 
This also supported that a linear regression model fit the data. The calibration curves for 
the three times were compared to the Zensor calibration curve as seen below in Figure 34 
and Figure 35. The calibration curve for the current output time of 42.3 seconds is the 
most comparable to the calibration curve for the Zensor. This data supported that the 3D-
printed sensor could accurately detect glucose solution concentrations between 0mg/dL 
and 400mg/dL. 
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Figure 34: Current verses glucose solution concentration for 3D-printed sensor based off 
readings at 3 seconds, 13 seconds, and 42.3 seconds, with Zensor comparison. 
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Figure 35: A) This is a representation of the 3D printed strip sensor calibration curve with 
the glucose solutions based off current readings at 42.3 seconds (N = 4) alongside the 
Zensor calibration curve. B) Normal probability plot of residuals versus the predicted 
current value for glucose concentrations at time of 42.3 seconds; there is no obvious 
pattern, which is evident of a good model. 
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CHAPTER 4 
CONCLUSION 
3D-Printed Sensor Verified Through Amperometric i-t Testing   
This research represents the first known work in developing a 3D-printed glucose 
monitoring sensor. It was determined that it is possible to 3D-print a glucose monitoring 
sensor. The sensor was determined to be sensitive to glucose concentrations between 0 
mg/dL to 400 mg/dL, which is a large enough range to properly manage diabetes. The 
results showed that there were minimal differences between the current output at various 
glucose solution concentrations between the industry standard Zensor and the 3D-printed 
graphene electrode. This showed that the 3D-printed sensor was responsive and sensitive.  
It was also determined that this device could be printed at a much lower cost than 
currently available devices. As seen below in Table 1, the cost of manufacturing the 
sensor was determined to be $0.40; however, this low cost for each sensor does not 
include the high initial cost of a 3D-printer. 3D-printers are continuing to become more 
affordable, so it is reasonable that in the future they will be a common household 
appliance. This would allow diabetics to print their own test strips at home for much less 
than SMBG test strips.  This would provide diabetics with a cost effective, accurate 
device that could reduce noncompliance issues due to the high cost of the test strips, 
ultimately improving their health outcomes. 
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Material Cost Per Test Strip 
Conductive Graphene PLA Filament $0.05 
Mylar Substrate $0.06 
GDH Enzyme $0.18 
PBS $0.05 
Ferricyanide $0.06 
Total: $0.40 
Table 1: Manufacturing cost for each 3D-printed test strip. 
 
This device could potentially prevent the serious complications caused by diabetes for 
millions of individuals around the world. Providing diabetics with this device not only 
will improve their health outcomes, but also will drive down the cost of other devices on 
the market. This technology also could be utilized in developing countries, as a local 
clinic could be supplied with a 3D-printer and filament and trained on how to use them. 
This would provide the clinics with the necessary testing supplies for managing and 
monitoring diabetes.  
This technology could be applied to other biomarkers. Biomarkers for pregnancy, cancer, 
and various diseases could be monitored using a 3D-printed sensor. This could allow 
hospitals to print the sensors as needed, which could reduce wasted resources. The 
SMBG industry could also transition from screen-printed electrodes to 3D-printed 
electrodes, which could lower the cost of SMBG test strips.  
 
Future Work 
There is a lot of work that still needs to be done on this device before it can be marketed 
to diabetics. A 3D-printer with a much higher resolution should be used to reduce the 
variance between prints. This would make all the sensors more uniform and reduce the 
  54 
porosity of the leads. Work must also be completed to reduce the volume of the liquid 
reagents needed in order to test the device. This can be done by creating a capture area to 
hold the reagents onto the leads. The technology from the TearTOUCH device could also 
be translated to this device, making the 3D-printed sensor not only affordable but also 
non-invasive. This could reduce noncompliance due to high cost of test strips and the 
pain that is associated with testing.  
It would also be useful to create a 3D-printer filament that contained the chemical 
reagents. This would eliminate the need for reagents to be applied after printing. Creating 
this filament could potentially be challenging as an enzyme could not be included in the 
filament. This is because of the high extrude temperature used in the printer would 
denature most enzymes. An enzyme with a high heat tolerance or a different chemical 
such as prussian blue could be used in this filament.  
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